peptide clinics and compounding pharmacies make AOD9604 available, but its typically labeled for research purposes only to comply with DSHEA (Dietary Supplement Health and Education Act) regulations (FDA compounding context)
Monitoring recommendations For those using AOD 9604 for extended periods, periodic health monitoring makes sense
The medicine is virtually non-toxic and has very few drug interactions
There is no advantage to using the light sensitive forms of cobalamin, such as methylB 12 or adenosylB 12 , instead of the stable cyano or hydroxy forms, which are readily converted in the body into the coenzyme forms, methylB 12 and adenosylB 12
This will be within 5 working days of the lab receiving your sample
That kind of regional convenience matters because weight loss is often a process, not a one-time event